The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Summary

OCID:: ocds-kuma6s-109829
Published by:: Cardiff University
Authority ID:: AA0258
Publication date:: 09 March 2022
Deadline date:: -
Notice type:: 03 Contract Award Notice - Incomplete Procedure
Has documents:: No
Has SPD:: No
Has Carbon Reduction Plan:: N/A

Abstract

Drug development Services CPV: 85142000, 85145000, 85148000, 85142000, 85142000, 85145000, 85148000, 85145000, 85142000, 85148000, 85142000, 85145000, 85148000, 85142000, 85145000, 85148000, 85145000, 85142000, 85148000, 85142000, 85145000, 85148000.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

Cardiff University

Procurement Services, McKenzie House, 30-36 Newport Road

Cardiff

CF24 0DE

Telephone: +44 2920879648

E-mail: tendersupport@cardiff.ac.uk

NUTS: UKL

Internet address(es)

Main address: http://www.cardiff.ac.uk/business/why-work-with-us/for-suppliers

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0258

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Education

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Drug Development Services

Reference number: CU.431.JD

II.1.2) Main CPV code

85142000

II.1.3) Type of contract

Services

II.1.4) Short description

Drug development Services

II.1.6) Information about lots

This contract is divided into lots: Yes

II.2) Description

Lot No: 1

II.2.1) Title

Electrophysiology Services

II.2.2) Additional CPV code(s)

85145000

85148000

85142000

II.2.3) Place of performance

NUTS code:

UKL22

II.2.4) Description of the procurement

We require providers for electrophysiology services relevant to neuroscience drug development.

II.2.5) Award criteria

Quality criterion: Quality / Weighting: 90

Price / Weighting: 10

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 2

II.2.1) Title

In-Vivo Rodent Behavioural Assays

II.2.2) Additional CPV code(s)

85142000

85145000

85148000

II.2.3) Place of performance

NUTS code:

UKL22

II.2.4) Description of the procurement

We require providers committed to the principles of the NC3Rs for in-vivo behavioural assays.

II.2.5) Award criteria

Quality criterion: Qulaity / Weighting: 90

Price / Weighting: 10

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 3

II.2.1) Title

In-Vitro ADME-Tox services

II.2.2) Additional CPV code(s)

85145000

85142000

85148000

II.2.3) Place of performance

NUTS code:

UKL22

II.2.4) Description of the procurement

We require providers of ADME-Tox services as part of our drug development pipeline.

II.2.5) Award criteria

Quality criterion: Quality / Weighting: 75

Price / Weighting: 25

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 4

II.2.1) Title

In-Vivo Rodent ADME-Tox

II.2.2) Additional CPV code(s)

85142000

85145000

85148000

II.2.3) Place of performance

NUTS code:

UKL22

II.2.4) Description of the procurement

We require providers committed to the principles of the NC3Rs for in-vivo ADME-Tox services.

II.2.5) Award criteria

Quality criterion: Quality / Weighting: 90

Price / Weighting: 10

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 5

II.2.1) Title

In-Vivo ADME-Tox (Non-Rodent)

II.2.2) Additional CPV code(s)

85142000

85145000

85148000

II.2.3) Place of performance

NUTS code:

UKL22

II.2.4) Description of the procurement

We require providers committed to the principles of the NC3Rs for in-vivo ADME-Tox services (not NHP).

II.2.5) Award criteria

Quality criterion: Quality / Weighting: 90

Price / Weighting: 10

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 6

II.2.1) Title

Manufacture of drug substance (API)

II.2.2) Additional CPV code(s)

85145000

85142000

85148000

II.2.3) Place of performance

NUTS code:

UKL22

II.2.4) Description of the procurement

We require active substance manufacturers with GMP certification for API manufacture.

II.2.5) Award criteria

Price

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 7

II.2.1) Title

Chemistry

II.2.2) Additional CPV code(s)

85142000

85145000

85148000

II.2.3) Place of performance

NUTS code:

UKL22

II.2.4) Description of the procurement

We require providers for chemistry services as part of our drug development pipeline.

II.2.5) Award criteria

Quality criterion: Quality / Weighting: 90

Price / Weighting: 10

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

Title: Chemistry

A contract/lot is awarded: No

V.1 Information on non-award

The contract/lot is not awarded

Other reasons (discontinuation of procedure)

Section VI: Complementary information

VI.3) Additional information

(WA Ref:119442)

VI.4) Procedures for review

VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

Telephone: +44 2079477501

VI.5) Date of dispatch of this notice

09/03/2022

Coding

Commodity categories

ID	Title	Parent category
85148000	Medical analysis services	Miscellaneous health services
85142000	Paramedical services	Miscellaneous health services
85145000	Services provided by medical laboratories	Miscellaneous health services

Delivery locations

ID	Description
1022	Cardiff and Vale of Glamorgan

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID	Description
There are no alert restrictions for this notice.

Document family

Notice details
APR362386: Drug Development Services Publication date: 15 April 2021 Deadline date: 08 March 2022 00:00 Notice type: 02 Contract Notice Authority name: Cardiff University
MAR391059: Drug Development Services Publication date: 09 March 2022 Notice type: 03 Contract Award Notice - Incomplete Procedure Authority name: Cardiff University

About the buyer

Main contact:: tendersupport@cardiff.ac.uk
Admin contact:: N/a
Technical contact:: N/a
Other contact:: N/a

Further information

Date	Details
No further information has been uploaded.

Drug Development Services

Contents

Summary

Abstract

Full notice text

Contract award notice

Section I: Contracting entity

I.1) Name and addresses

I.2) Joint procurement

I.4) Type of the contracting authority

I.5) Main activity

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

II.1.2) Main CPV code

II.1.3) Type of contract

II.1.4) Short description

II.1.6) Information about lots

II.2) Description

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.5) Award criteria

II.2.11) Information about options

II.2.13) Information about European Union funds

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.5) Award criteria

II.2.11) Information about options

II.2.13) Information about European Union funds

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.5) Award criteria

II.2.11) Information about options

II.2.13) Information about European Union funds

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.5) Award criteria

II.2.11) Information about options

II.2.13) Information about European Union funds

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.5) Award criteria

II.2.11) Information about options

II.2.13) Information about European Union funds

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.5) Award criteria

II.2.11) Information about options

II.2.13) Information about European Union funds

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.5) Award criteria

II.2.11) Information about options

II.2.13) Information about European Union funds

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Section V: Award of contract

V.1 Information on non-award

Section V: Award of contract

V.1 Information on non-award

Section V: Award of contract

V.1 Information on non-award